Atlas Trials

An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates

Clinical trial NCT02819102 · COMPLETED

Trial details

NCT number
NCT02819102
Sponsor
BioCryst Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hereditary Angioedema
Start date
2016-03-01
Primary completion
2016-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.